These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Tanaka H; Yamamoto M; Hashimoto N; Miyakoshi M; Tamakawa S; Yoshie M; Tokusashi Y; Yokoyama K; Yaginuma Y; Ogawa K Cancer Res; 2006 Dec; 66(23):11263-70. PubMed ID: 17145871 [TBL] [Abstract][Full Text] [Related]
26. Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas. Yunokawa M; Tanimoto K; Nakamura H; Nagai N; Kudo Y; Kawamoto T; Kato Y; Hiyama E; Hiyama K; Nishiyama M Oncol Rep; 2007 Apr; 17(4):871-8. PubMed ID: 17342330 [TBL] [Abstract][Full Text] [Related]
27. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523 [TBL] [Abstract][Full Text] [Related]
28. Glycolysis-related protein expression in thyroid cancer. Nahm JH; Kim HM; Koo JS Tumour Biol; 2017 Mar; 39(3):1010428317695922. PubMed ID: 28347233 [TBL] [Abstract][Full Text] [Related]
29. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890 [TBL] [Abstract][Full Text] [Related]
30. Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines. Piscazzi A; Costantino E; Maddalena F; Natalicchio MI; Gerardi AM; Antonetti R; Cignarelli M; Landriscina M J Clin Endocrinol Metab; 2012 Jun; 97(6):E898-906. PubMed ID: 22442268 [TBL] [Abstract][Full Text] [Related]
31. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
32. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer. Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909 [TBL] [Abstract][Full Text] [Related]
33. Mutation of the PIK3CA gene in anaplastic thyroid cancer. García-Rostán G; Costa AM; Pereira-Castro I; Salvatore G; Hernandez R; Hermsem MJ; Herrero A; Fusco A; Cameselle-Teijeiro J; Santoro M Cancer Res; 2005 Nov; 65(22):10199-207. PubMed ID: 16288007 [TBL] [Abstract][Full Text] [Related]
34. Hypoxia Increases Thyroid Cancer Stem Cell-Enriched Side Population. Mahkamova K; Latar N; Aspinall S; Meeson A World J Surg; 2018 Feb; 42(2):350-357. PubMed ID: 29167950 [TBL] [Abstract][Full Text] [Related]
35. BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I. Ellinghaus P; Heisler I; Unterschemmann K; Haerter M; Beck H; Greschat S; Ehrmann A; Summer H; Flamme I; Oehme F; Thierauch K; Michels M; Hess-Stumpp H; Ziegelbauer K Cancer Med; 2013 Oct; 2(5):611-24. PubMed ID: 24403227 [TBL] [Abstract][Full Text] [Related]
36. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma. Petrella BL; Brinckerhoff CE Cancer Biol Ther; 2009 Jul; 8(14):1389-401. PubMed ID: 19483472 [TBL] [Abstract][Full Text] [Related]
37. The role of carbonic anhydrase IX in hypoxia control in OSCC. Pérez-Sayáns M; Supuran CT; Pastorekova S; Suárez-Peñaranda JM; Pilar GD; Barros-Angueira F; Gándara-Rey JM; García-García A J Oral Pathol Med; 2013 Jan; 42(1):1-8. PubMed ID: 22417164 [TBL] [Abstract][Full Text] [Related]
38. Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma. Mayer A; Schneider F; Vaupel P; Sommer C; Schmidberger H Int J Oncol; 2012 Oct; 41(4):1260-70. PubMed ID: 22825389 [TBL] [Abstract][Full Text] [Related]
39. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma. Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515 [TBL] [Abstract][Full Text] [Related]
40. Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma. Baitei EY; Zou M; Al-Mohanna F; Collison K; Alzahrani AS; Farid NR; Meyer B; Shi Y J Pathol; 2009 Apr; 217(5):707-15. PubMed ID: 19156774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]